Palvella Therapeutics

Palvella Therapeutics

Palvella Therapeutics

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.
Founded
2015
Raised
$57.5M
Follow us
Alexa global traffic share
Latest funding Show all
$45,000,000
Venture capital (Series C) - 2020
Adams Street Partners BioAdvance Samsara BioCapital +6
$10,000,000
Venture capital - 2018
Ligand Pharmaceuticals
Team Size
1–10
Employees
$45,000,000 Venture capital (Series C)
FinSMEs

Palvella Therapeutics Closes $45M Series C Financing Round

$10,000,000 Venture capital
FinSMEs

Palvella Therapeutics Receives $10M in Funding